ELEXtensions ELEX WordPress HelpDesk & Customer Ticketing System Plugin cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.7 | $0-$5k | 0.00 |
Summary
A vulnerability has been found in ELEXtensions ELEX WordPress HelpDesk & Customer Ticketing System Plugin up to 3.3.4 on WordPress and classified as problematic. This affects an unknown function. The manipulation leads to cross site scripting. This vulnerability is uniquely identified as CVE-2025-9343. The attack is possible to be carried out remotely. No exploit exists.
Details
A vulnerability was found in ELEXtensions ELEX WordPress HelpDesk & Customer Ticketing System Plugin up to 3.3.4 on WordPress. It has been rated as problematic. This issue affects an unknown part. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. The summary by CVE is:
The ELEX WordPress HelpDesk & Customer Ticketing System plugin for WordPress is vulnerable to Stored Cross-Site Scripting via ticket subjects in all versions up to, and including, 3.3.4 due to insufficient input sanitization and output escaping. This makes it possible for unauthenticated attackers to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page.
The advisory is shared at wordfence.com. The identification of this vulnerability is CVE-2025-9343. The exploitation is known to be easy. The attack may be initiated remotely. No form of authentication is needed for a successful exploitation. It demands that the victim is doing some kind of user interaction. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2025-204662). Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Type
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.7VulDB Meta Temp Score: 5.7
VulDB Base Score: 4.3
VulDB Temp Score: 4.2
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 7.2
CNA Vector: 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
12/20/2025 Advisory disclosed12/20/2025 VulDB entry created
12/21/2025 VulDB entry last update
Sources
Advisory: wordfence.comStatus: Not defined
CVE: CVE-2025-9343 (🔒)
GCVE (CVE): GCVE-0-2025-9343
GCVE (VulDB): GCVE-100-337697
EUVD: 🔒
Entry
Created: 12/20/2025 18:01Updated: 12/21/2025 07:31
Changes: 12/20/2025 18:01 (51), 12/21/2025 05:34 (12), 12/21/2025 07:31 (1)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.